GOCAX
Price
$15.64
Change
-$0.18 (-1.14%)
Updated
Jul 31 closing price
Net Assets
6.34M
OSCIX
Price
$37.49
Change
-$0.44 (-1.16%)
Updated
Jul 31 closing price
Net Assets
2.39B
Interact to see
Advertisement

GOCAX vs OSCIX

GOCAX vs OSCIX Comparison Chart in %
View a ticker or compare two or three
VS
GOCAX vs. OSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GOCAX is a Buy and OSCIX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
OSCIX has more cash in the bank: 2.39B vs. GOCAX (6.34M). GOCAX pays higher dividends than OSCIX: GOCAX (1.90) vs OSCIX (1.80). GOCAX was incepted earlier than OSCIX: GOCAX (26 years) vs OSCIX (15 years). GOCAX (4.00) is less costly to investors than OSCIX (1.01). OSCIX is a more actively managed with annual turnover of: 52.00 vs. GOCAX (13.00). GOCAX has a lower initial minimum investment than OSCIX: GOCAX (1000) vs OSCIX (1000000). GOCAX annual gain was more profitable for investors over the last year : 17.79 vs. OSCIX (-8.63). GOCAX return over 5 years is better than : 1.21 vs. OSCIX (-35.91).
GOCAXOSCIXGOCAX / OSCIX
Total Expense Ratio0.911.0190%
Annual Report Gross Expense Ratio4.001.01396%
Fund Existence26 years15 years-
Gain YTD0.5146.3558%
Front Load6%N/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets6.34M2.39B0%
Annual Yield % from dividends1.901.80106%
Returns for 1 year17.79-8.63-206%
Returns for 3 years31.60-7.31-432%
Returns for 5 years1.21-35.91-3%
Returns for 10 years-30.777.25-425%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IJEMX17.050.40
+2.40%
VY® JPMorgan Emerging Markets Equity I
TVLRX12.670.05
+0.40%
Touchstone Value R6
JCMAX67.92-0.17
-0.25%
JPMorgan Mid Cap Equity A
JSCGX21.55-0.13
-0.60%
Jacob Small Cap Growth Investor
ETIHX55.90-0.92
-1.62%
Eventide Healthcare & Life Sciences I